一种抗NLOS的TDOA定位算法

本文提出了一种抗非视线传播(Non-Line-of-Sight)干扰的TDOA定位算法。该算法采用退火与遗传算法相结合的方式，在满足给定条件的空间内搜索源点坐标值。数值仿真表明，该算法具备抗NLOS干扰的能力，与传统TDOA算法相比，该算法无需知道各基站的非视线传播干扰分布，是一种实用有效的定位算法。     

The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), the most common malignant tumor in the liver, grows and metastasizes rapidly. Despite advances in treatment modalities, the five-year survival rate of HCC remains less than 30%. We sought genetic mutations that may affect the oncogenic properties of HCC, using The Cancer Genome Atlas (TCGA) data analysis. We found that the GNAQ T96S mutation (threonine 96 to serine alteration of the Gαq protein) was present in 12 out of 373 HCC patients (3.2%). To examine the effect of the GNAQ T96S mutation on HCC, we transfected the SK-Hep-1 cell line with the wild-type or the mutant GNAQ T96S expression vector. Transfection with the wild-type GNAQ expression vector enhanced anchorage-independent growth, migration, and the MAPK pathways in the SK-Hep-1 cells compared to control vector transfection. Moreover, cell proliferation, anchorage-independent growth, migration, and the MAPK pathways were further enhanced in the SK-Hep-1 cells transfected with the GNAQ T96S expression vector compared to the wild-type GNAQ-transfected cells. In silico structural analysis shows that the substitution of the GNAQ amino acid threonine 96 with a serine may destabilize the interaction between the regulator of G protein signaling (RGS) protein and GNAQ. This may reduce the inhibitory effect of RGS on GNAQ signaling, enhancing the GNAQ signaling pathway. Single nucleotide polymorphism (SNP) genotyping analysis for Korean HCC patients shows that the GNAQ T96S mutation was found in only one of the 456 patients (0.22%). Our data suggest that the GNAQ T96S hotspot mutation may play an oncogenic role in HCC by potentiating the GNAQ signal transduction pathway.     

BRAF Gene and Melanoma: Back to the Future

As widely acknowledged, 40–50% of all melanoma patients harbour an activating BRAF mutation (mostly BRAF V600E). The identification of the RAS–RAF–MEK–ERK (MAP kinase) signalling pathway and its targeting has represented a valuable milestone for the advanced and, more recently, for the completely resected stage III and IV melanoma therapy management. However, despite progress in BRAF-mutant melanoma treatment, the two different approaches approved so far for metastatic disease, immunotherapy and BRAF+MEK inhibitors, allow a 5-year survival of no more than 60%, and most patients relapse during treatment due to acquired mechanisms of resistance. Deep insight into BRAF gene biology is fundamental to describe the acquired resistance mechanisms (primary and secondary) and to understand the molecular pathways that are now being investigated in preclinical and clinical studies with the aim of improving outcomes in BRAF-mutant patients.     

Computational-Driven Epitope Verification and Affinity Maturation of TLR4-Targeting Antibodies

Toll-like receptor (TLR) signaling plays a critical role in the induction and progression of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematous, experimental autoimmune encephalitis, type 1 diabetes mellitus and neurodegenerative diseases. Deciphering antigen recognition by antibodies provides insights and defines the mechanism of action into the progression of immune responses. Multiple strategies, including phage display and hybridoma technologies, have been used to enhance the affinity of antibodies for their respective epitopes. Here, we investigate the TLR4 antibody-binding epitope by computational-driven approach. We demonstrate that three important residues, i.e., Y328, N329, and K349 of TLR4 antibody binding epitope identified upon in silico mutagenesis, affect not only the interaction and binding affinity of antibody but also influence the structural integrity of TLR4. Furthermore, we predict a novel epitope at the TLR4-MD2 interface which can be targeted and explored for therapeutic antibodies and small molecules. This technique provides an in-depth insight into antibody–antigen interactions at the resolution and will be beneficial for the development of new monoclonal antibodies. Computational techniques, if coupled with experimental methods, will shorten the duration of rational design and development of antibody therapeutics.     

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

The aim of this study was exploration of the genetic background of conjunctival melanoma (CM) and correlation with recurrent and metastatic disease. Twenty-eight CM from the Rotterdam Ocular Melanoma Study group were collected and DNA was isolated from the formalin-fixed paraffin embedded tissue. Targeted next-generation sequencing was performed using a panel covering GNAQ, GNA11, EIF1AX, BAP1, BRAF, NRAS, c-KIT, PTEN, SF3B1, and TERT genes. Recurrences and metastasis were present in eight (29%) and nine (32%) CM cases, respectively. TERT promoter mutations were most common (54%), but BRAF (46%), NRAS (21%), BAP1 (18%), PTEN (14%), c-KIT (7%), and SF3B1 (4%) mutations were also observed. No mutations in GNAQ, GNA11, and EIF1AX were found. None of the mutations was significantly associated with recurrent disease. Presence of a TERT promoter mutation was associated with metastatic disease (p-value = 0.008). Based on our molecular findings, CM comprises a separate entity within melanoma, although there are overlapping molecular features with uveal melanoma, such as the presence of BAP1 and SF3B1 mutations. This warrants careful interpretation of molecular data, in the light of clinical findings. About three quarter of CM contain drug-targetable mutations, and TERT promoter mutations are correlated to metastatic disease in CM.     

基于SDNA-GA 优化的模糊神经网络控制

针对最新的生物DNA研究,病毒中同一DNA碱基顺序可以编码出2条或者3条不同的多肽链.在此基础上分析与模仿了重叠基因和重叠密码的机理,得到一种新的基于重叠基因编码框架,从而提高了问题求解的效率;同时,得到一种移码解读框架的DNA遗传算法(SDNA-GA)计算模型,并将其应用于一类广义隶属度型T-S模糊神经网络控制器(GTS-FNNC)的优化设计,实现了GTS-FNNC的在线学习.     

紫外诱变柠檬酸生产菌黑曲霉的选育

初步研究了柠檬酸生产菌黑曲霉产柠檬酸的影响因素和培养条件,通过紫外诱变考察了出发菌株的受诱变性,统计了紫外诱变黑曲霉引起的生物学效应,在紫外诱变过程中筛选到一株稳定高产菌株10min-3,产酸增加了5.33%,可作为进一步诱变筛选的出发菌株.     

Bioleaching of chalcocite by mixed microorganisms subjected to mutation

Mixed microorganisms with elevated activity of chalcocite-leaching were screened by mutation methods. The original microorganisms collected from acid mine drainage of different sites were mixed and then treated with mutagens NO₂⁻, diethyl sulfate (DES), UV and their combinations, respectively. Five groups of mixed microorganisms with much stronger ore-leaching ability were obtained by screening on the leaching media. Among them, group E of mixed microorganisms (treated with 1% DES for 60 min) with the best performance on chalcocite-leaching, increases the content of Cu²⁺ by 101.4% in 20 d of leaching compared with the control culture. In addition, group E is more tolerant to Cu²⁺ in media than the control without mutation treatment. Analysis for the diversity of microbial clones indicates that half of operational taxonomic units (OTUs) in group E are Acidithiobacillus ferrooxidans. These observations suggest that group E might have potentials for industrial application. Foundation item: Project(50321402) supported by the National Natural Science Foundation of China; Project(2004CB619201) supported by the Major State Basic Research and Development Program of China     

胆固醇氧化酶高产菌株的诱变选育及产酶条件优化

在对细脚拟青霉、玫烟色拟青霉、粉拟青霉、香菇、平菇、金针菇等胆固醇氧化酶产生菌初筛的基础上．选择以产酶较高的玫烟色拟青霉作为紫外诱变的出发菌株,筛选出一株相对高产突变菌株MFEC006,其酶活达到了0．5483U／mL,比出发菌株提高了154％,经8次传代培养,突变株性质稳定．对MFEC006菌株产酶条件进行优化,得出其最佳产酶条件为：pH为6．5,温度27℃,接种量10％,摇床转速180r／min．     

基于改进NSGA-II的车间排产优化算法研究

针对NSGA-II算法在处理车间排产优化问题中出现的子代种群多样性差、收敛能力差等问题,提出了一种改进NSGA-II的车间排产优化算法。改进NSGA-II算法主要对传统NSGA-II算法的交叉和变异环节,提出新的改进自适应交叉和变异算子,通过对个体拥挤度与种群平均拥挤度进行对比,并结合种群迭代进化过程,将遗传概率与种群个体及种群进化迭代次数关联,避免盲目导向性,提高种群的收敛速度;提出新的均匀进化精英保留策略,通过自适应分层次选取种群个体,解决子代种群多样性差的问题。针对车间排产问题,选择“最大化最小交货提前期”和“最小化最大理想加工时间偏差”作为目标函数,运用改进NSGA-II算法进行实际工程的仿真分析,对比改进前后算法优化的结果,验证了算法的有效性,同时证明了其应用于实际生产排产调度问题的价值参考性。